000			01480 a2200397 4500
005			20250517151457.0
264		0	_c20180205
008			201802s 0 0 eng d
022			_a1873-2518
024	7		_a10.1016/j.vaccine.2017.03.008 _2doi
040			_aNLM _beng _cNLM
100	1		_aAnand, Abhijeet
245	0	0	_aImmunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule. _h[electronic resource]
260			_bVaccine _c05 2017
300			_a2993-2998 p. _bdigital
500			_aPublication Type: Journal Article; Review; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAntibodies, Neutralizing _xblood
650	0	4	_aAntibodies, Viral _xblood
650	0	4	_aDose-Response Relationship, Immunologic
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunization Schedule
650	0	4	_aImmunogenicity, Vaccine
650	0	4	_aInfant
650	0	4	_aInjections, Intradermal
650	0	4	_aMale
650	0	4	_aPoliomyelitis _xprevention & control
650	0	4	_aPoliovirus _xclassification
650	0	4	_aPoliovirus Vaccine, Inactivated _xadministration & dosage
650	0	4	_aSeroconversion
700	1		_aMolodecky, Natalie A
700	1		_aPallansch, Mark A
700	1		_aSutter, Roland W
773	0		_tVaccine _gvol. 35 _gno. 22 _gp. 2993-2998
856	4	0	_uhttps://doi.org/10.1016/j.vaccine.2017.03.008 _zAvailable from publisher's website
999			_c27105416 _d27105416